NYQ · Key Statistics

Bausch Health Companies Inc. (BHC) P/E Ratio, ROE & Key Statistics

$8.77 NYQ: BHC Market Cap $3.28B

Data as of Nov 18, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Bausch Health Companies Inc. (BHC), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-3.68
P/B ratioShare price divided by book value per share.-2.36
P/S ratioMarket value divided by annual revenue.0.28
PEG ratioP/E divided by the earnings growth rate.0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.8.94
EV / RevenueEnterprise value against annual revenue.1.92
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.-50.00%
Free cash flow yieldFree cash flow as a percentage of market value.58.45%
Price / free cash flowMarket value divided by free cash flow.3.12

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.72.62%
Operating marginRevenue left after operating costs.27.97%
Net marginRevenue left after every cost, including tax and interest.-7.57%
Return on equityProfit as a percentage of shareholders’ equity.58.90%
Return on assetsProfit as a percentage of total assets.-3.30%
Return on capital employedOperating profit against the capital the business uses.14.99%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.1.56
Quick ratioThe same, excluding inventory.1.22
Cash ratioCash alone against current liabilities.0.32
Debt to equityTotal borrowings against shareholders’ equity.-15.60
Debt to assetsTotal borrowings against total assets.0.81
Interest coverageHow many times operating profit covers the interest bill.1.95

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.$0.43
Market capitalisationShare price times shares outstanding.$3.28B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.$23.90B

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

Bausch Health Companies Inc. (BHC) statistics — frequently asked questions

What is Bausch Health Companies Inc.'s P/E ratio?

Bausch Health Companies Inc. (BHC) trades on a price-to-earnings ratio of -3.68. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Bausch Health Companies Inc.'s return on equity?

Bausch Health Companies Inc. (BHC) reports a return on equity of 58.90%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Bausch Health Companies Inc. carry?

Bausch Health Companies Inc. (BHC) has a debt-to-equity ratio of -15.60, which compares total borrowings with shareholders' equity.

What is Bausch Health Companies Inc.'s profit margin?

Bausch Health Companies Inc. (BHC) keeps -7.57% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Drug Manufacturers - Specialty & Generic stocks

TEVA P/E 94.73ZTS P/E 13.82VTRS ROE -4.24%ELAN ROE -2.24%RDY P/E 39.94ALKS key statisticsAMRX P/E 50.49LNTH P/E 24.54SUPN ROE -4.14%RGC ROE -160.64%All Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.